Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GINKGO BIOWORKS HOLDINGS, INC.

(DNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/14/2021 10/15/2021 10/18/2021 10/19/2021 10/20/2021 Date
11.63(c) 11.91(c) 12.32(c) 14.81(c) 13.77(c) Last
6 221 365 7 825 021 6 449 732 15 424 778 6 934 466 Volume
+13.46% +2.41% +3.44% +20.21% -7.02% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 180 M - -
Net income 2021 -228 M - -
Net cash position 2021 1 653 M - -
P/E ratio 2021 -125x
Yield 2021 -
Sales 2022 227 M - -
Net income 2022 -163 M - -
Net cash position 2022 1 375 M - -
P/E ratio 2022 -154x
Yield 2022 -
Capitalization 26 953 M 26 953 M -
EV / Sales 2021 140x
EV / Sales 2022 113x
Nbr of Employees 495
Free-Float 79,2%
More Financials
Company
Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug... 
More about the company
All news about GINKGO BIOWORKS HOLDINGS, INC.
10/20QUEST DIAGNOSTICS INCORPORATED : Teams Up With Ginkgo Bioworks to Provide K-12 School COVI..
MT
10/20Quest Diagnostics to Provide Covid-19 School Testing Services in Texas
DJ
10/20QUEST DIAGNOSTICS : to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo B..
PR
10/20GINKGO BIOWORKS : Announces Participation in Jefferies Gene Therapy/Editing Summit
PR
10/20CRONOS : Launches Edible Cultured Cannabinoid Product in Canada
MT
10/19GINKGO BIOWORKS : Shares Extend Rally Tuesday Afternoon
MT
10/15SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkg..
PR
10/14GINKGO BIOWORKS : Shares Climb in Slack Trading
MT
10/13GINKGO BIOWORKS : Raymond James Starts Ginkgo Bioworks Holdings at Outperform with $14.50 ..
MT
10/12GINKGO BIOWORKS : William Blair Starts Ginkgo Bioworks Holdings at Outperform
MT
10/08GINKGO INVESTIGATION ALERT : Kessler Topaz Meltzer & Check, LLP is Investigating Securitie..
PR
10/08INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Gin..
PR
10/07GINKGO ALERT : Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc...
BU
10/07DNA BREAKING NEWS : ROSEN, LEADING INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, ..
PR
10/07SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkg..
PR
More news
News in other languages on GINKGO BIOWORKS HOLDINGS, INC.
10/20Quest Diagnostics s'associe à Ginkgo Bioworks pour proposer des tests COVID-19 dans les..
10/19Les actions de Ginkgo Bioworks prolongent leur rallye mardi après-midi
10/14Les actions de Ginkgo Bioworks grimpent dans un marché calme
10/06Le secteur de la santé reste à l'écart de la progression des marchés plus larges cet ap..
10/06Les actions de Ginkgo Bioworks plongent après un rapport de Scorpion Capital, un vendeu..
More news
Analyst Recommendations on GINKGO BIOWORKS HOLDINGS, INC.
More recommendations
Chart GINKGO BIOWORKS HOLDINGS, INC.
Duration : Period :
Ginkgo Bioworks Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GINKGO BIOWORKS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 13,77 $
Average target price 14,25 $
Spread / Average Target 3,49%
EPS Revisions
Managers and Directors
Jason Kelly Chief Executive Officer & Director
Reshma Shetty President, Chief Operating Officer & Director
Mark Dmytruk Chief Financial Officer
Arie S. Belldegrun Independent Director
Marijn E. Dekkers Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GINKGO BIOWORKS HOLDINGS, INC.0.00%26 953
MODERNA, INC.218.76%134 418
LONZA GROUP AG29.18%59 339
IQVIA HOLDINGS INC.40.38%48 194
SEAGEN INC.-0.17%31 811
CELLTRION, INC.-39.00%25 446